Pagina 5 - I migliori medici per il trattamento di Cancro al seno - TOP-171 medici

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Dr. Tamer Mostafa Manie is an Associate Professor of Surgical Oncology at the National Cancer Institute, Cairo University. He is also a Consultant Breast and Oncoplastic Surgeon at Shefa Al Orman. He performs breast cancer surgery and reconstruction. His work includes CBS, mastectomy, and lumpectomy. He performs sentinel and axillary staging. He offers implant and expander reconstruction and flap options (LD, TDAP, LICAP, AICAP, TRAM, SEAP). He also performs supermicrosurgery for lymphedema. He was Breast Cancer MDT Chairman at Madinet Nasr Oncology Center from 2021 to 2023.

Qualifications: MBBCh (2003), Master’s in Surgical Oncology (2009), Doctorate in Surgical Oncology (2014). International training: Heart of England NHS Trust (2013), European Institute of Oncology, Milan (2013–2014), Nottingham Breast Institute (2023). Memberships: EGSSO and the European Society of Surgical Oncology.

Dr. Tarek M. Hashem is an Associate Professor of Surgical Oncology at the National Cancer Institute, Cairo University (since 2020). He is also a Consultant in Breast and Oncoplastic Surgery at Shefa Al Orman Comprehensive Cancer Center in Luxor (2018–present).

Focus: breast cancer management and oncoplastic surgery. Procedures include breast-conserving surgery, mastectomy, and lumpectomy. Axillary staging includes sentinel lymph node biopsy and axillary dissection. He performs reduction mammoplasty and mastopexy. Reconstruction options include implants, expanders, and flaps (LD, TDAP, LICAP, AICAP, TRAM, SEAP), as well as nipple reconstruction and lipofilling. He also performs supermicrosurgery for lymphedema.

Credentials: MBBCh (Kasr El-Aini, Cairo University). MRCS (England, 2008). Master’s in General Surgery (Kasr El-Aini, Cairo University, 2009). International Breast Surgery Fellowship per EUSOMA (Marienhospital Düsseldorf, 2011). Fellowship in Breast Surgery (Heidelberg University Hospital, 2013). Doctoral degree in Surgical Oncology (2015).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Il medico è un oncologo altamente esperto con un focus sul trattamento e la gestione del cancro. Con anni di pratica dedicata, il medico ha contribuito in modo significativo ai progressi in oncologia, implementando terapie all'avanguardia e partecipando a ricerche volte a migliorare i risultati dei pazienti. Il medico è riconosciuto per la sua leadership all'interno della comunità oncologica, avendo ricoperto ruoli chiave che guidano l'innovazione e la cura di qualità nel trattamento del cancro. La loro esperienza clinica è completata da un impegno per la cura centrata sul paziente e lo sviluppo professionale continuo.<\/p>

RESEARCH ACTIVITY

1998–2000 — Conducted research on the genesis of cancer at The Royal Marsden Hospital (England).

PUBLICATIONS

Authored numerous peer-reviewed articles in scientific journals. Selected topics include:

Oncotype Dx Recurrence Score in BRCA1/2 germline mutation carriers with hormone receptor-positive breast cancer.

TP53 missense mutation recurrence in cancer patients of Arab descent.

Adjuvant autologous vaccine for stage III microscopic melanoma: biomarker survival and enhanced response to CTLA-4 blockade.

Prognostic significance of (R)CA15-3 assay in primary breast cancer.

Diagnostic and prognostic value of comparative thymidine kinase 1 (TK1) activity assays in breast cancer patient serum.

Complete remission in a BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma treated with cisplatin.

Autologous vaccine-induced antitumor and self-reactive immune responses in melanoma: impact on patient survival and dependence on MHC class II expression.

PROFESSIONAL AFFILIATIONS

Israeli Society of Clinical Oncology

Israel Medical Association

AWARDS & GRANTS

Cancer Genetics Research Foundation Award

Landau Prize

Judith Segal Memorial Award

Dr. Joseba Rebollo Liceaga is a seasoned medical oncologist with a comprehensive background in oncology.​

Education and Training:

Graduated in Medicine and Surgery from the University of Navarra (1985).​

Completed residency in Oncology in 1987.​

Specialist in Medical Oncology at the Clínica Universidad de Navarra (1991).​

Professional Experience:

Head of the Oncology Department at Clínica San Miguel de Navarra (1991–2004).​

Associate Physician at the University Clinic of the Faculty of Medicine, University of Navarra (1995–2002).​

Adjunct Physician at the Oncology Platform, Hospital Quirónsalud Torrevieja (2004–2014).

Head of the Oncology Department at Hospital General de Villalba (2014–2019).​

Currently practices as a Medical Oncology Specialist at Quirónsalud Alicante.​

Certifications and Training:

Completed multiple accredited courses in Multidisciplinary Oncology between 2003 and 2006.​

Research and Publications:

Authored research on electrochemotherapy and multidisciplinary treatment approaches in oncology.

La dottoressa è un'oncologa presso il Centro Medico Hadassah, avendo conseguito un Dottorato in Scienze Mediche presso l'Università Ebraica di Gerusalemme. Ha completato un tirocinio presso il prestigioso Centro Oncologico Sloan-Kettering di New York, migliorando la sua esperienza in oncologia.<\/p>

Nel 1994, è diventata capo dell'Istituto di Oncologia e successivamente, nel 1998, ha guidato il Centro di Trattamento del Cancro al Seno. Entro il 2006, è stata nominata Professore del Dipartimento di Oncologia presso l'Università Ebraica. È attivamente coinvolta con diverse organizzazioni internazionali sul cancro ed è stata riconosciuta con una borsa di studio dalla Scuola Medica Hadassah.<\/p>

Education and Expertise

• ANKARA UNIVERSITY FACULTY OF MEDICINE

Diseases

• Brain Tumors
• Gastrointestinal Cancers
• Genitourinary Cancers
• Lymphoma
• Malign Melanoma
• Breast Cancer
• Sarcomas

Experience

• Internal Medicine Specialist; Süleyman Demirel University Medical Faculty Hospital Internal Medicine Department
• Medical Oncology Specialist; Hacettepe University Faculty of Medicine Oncology Hospital, Department of Medical Oncology

Professional Memberships

• ESMO (European Society for Medical Oncology), full membership
• Turkish Medical Oncology Association, full membership

Il medico è un radioterapista altamente esperto, specializzato in tecniche avanzate di terapia radiante per il trattamento del cancro. Con oltre 15 anni di pratica, ha contribuito in modo significativo al campo attraverso la ricerca e le sperimentazioni cliniche, con l'obiettivo di migliorare i risultati dei pazienti. Il medico è stato riconosciuto per la sua esperienza in radiochirurgia stereotassica e terapia radiante modulata in intensità, fornendo cure all'avanguardia ai pazienti. Ha pubblicato numerosi articoli sottoposti a revisione paritaria ed è un frequente relatore in conferenze internazionali di oncologia.<\/p>

 Posts and Affiliations

Clinical Director – Multidisciplinary Breast Unit Kliniken Essen-Mitte, Germany

Lead Breast Cancer Research Program, Kliniken Essen-Mitte

Executive Board Member of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)

 Additional Roles

ESMO Faculty – Breast Cancer

Member of AWO Gyn – Commission for plastic and reconstructive surgery

Speaker of the AGIMed – Commission for Integrative Medicine of the AGO

Member of the Organ Commission Mamma of the AGO

Scientific Director of the WSG study group

Global PI, Head of clinical investigations and trials 27

IDMC´s, Steering Boards national and international

Scientific committee of international and national symposia in breast cancer and surgical oncology

 Organization Memberships

Memberships: European Society of Medical Oncology, American Society of Clinical Oncology,

European Academy of Senology, German Cancer Society, German Society of Gynecology and

Obstetrics, Working Group for Gynecological Oncology, German Society of Senology,

 Publications

Peer reviewed Publications: 322

First/Senior Author: 38

h-Index/i10-Index 66/232

Congress Abstracts/Proceedings: 443

Books/Book Chapter: 59

Invited oral Presentations/Lectures: 1032

Il medico è un oncologo altamente esperto con un focus su metodologie innovative di trattamento del cancro. Con oltre 15 anni di pratica clinica, il medico ha trattato con successo una vasta gamma di malignità utilizzando terapie all'avanguardia e approcci di medicina personalizzata. Il medico è certificato dal consiglio e ha contribuito a numerose pubblicazioni sottoposte a revisione paritaria in riviste di oncologia. Inoltre, il medico è stato coinvolto in diversi progetti di ricerca rivoluzionari mirati a migliorare i risultati dei pazienti e ha presentato i risultati in conferenze internazionali.<\/p>

Il medico è un oncologo altamente esperto con un focus su trattamenti innovativi per il cancro e cure personalizzate per i pazienti. Con oltre 15 anni di esperienza nel campo, il medico ha contribuito significativamente ai progressi nella chemioterapia e nell'immunoterapia. Il medico è certificato dal consiglio e ha pubblicato numerosi articoli di ricerca su riviste mediche prestigiose. Il medico è anche attivamente coinvolto in studi clinici ed è stato relatore principale in diverse conferenze internazionali di oncologia.<\/p>

Il medico è un oncoginecologo affermato con vasta esperienza nel trattamento dei tumori ginecologici. Specializzandosi in tecniche chirurgiche avanzate e piani di trattamento personalizzati, il medico ha contribuito significativamente a migliorare i risultati dei pazienti. Con un forte focus sulla ricerca e l'innovazione, il medico ha pubblicato numerosi articoli su riviste mediche prestigiose, evidenziando i progressi nelle procedure minimamente invasive e nelle terapie mirate. Il medico è certificato e partecipa attivamente a conferenze mediche di primo piano, condividendo la propria esperienza con colleghi di tutto il mondo.<\/p>

Il medico è un chirurgo plastico ricostruttivo di spicco in Israele, specializzato in ricostruzione e ingrandimento del seno, chirurgia plastica e ricostruttiva del viso e microchirurgia.<\/p>

Attualmente, il medico è Direttore del Dipartimento di Chirurgia Plastica e Ricostruttiva della Testa e del Collo e del Centro Testa e Collo presso il Centro Medico Rambam.<\/p>

Educato presso la Scuola Medica Americana del Technion in Israele, con una laurea in medicina generale e specializzazione in chirurgia plastica, ha completato un tirocinio presso la Baylor University negli Stati Uniti.<\/p>

Impegnato nella ricerca scientifica sulle cause genetiche del cancro al seno e sulla reinervazione mammaria post-chirurgica.<\/p>

Il medico è uno scienziato clinico con esperienza nell'applicazione clinica dei risultati di laboratorio nel cancro al seno, concentrandosi sull'espressione genica e sui sottotipi molecolari. Il medico progetta e guida studi clinici per nuovi farmaci e approcci presso SOLTI, un gruppo cooperativo spagnolo sul cancro al seno.<\/p>

Dopo essersi laureato in medicina presso l'Università di Barcellona nel 2003, il medico ha completato una borsa di studio in oncologia medica presso l'Istituto di Oncologia Vall d'Hebron e ricerche post-dottorato presso l'Università della Carolina del Nord.<\/p>

Attualmente, il medico dirige il Gruppo di Genomica Traslazionale e Terapie Mirate nei Tumori Solidi presso IDIBAPS ed è il Presidente del Consiglio di Amministrazione di SOLTI. Il medico ha co-fondato Reveal Genomics e detiene tre brevetti.<\/p>

Con oltre 160 pubblicazioni e un indice H di 51, il medico è stato citato 13.479 volte e ha presentato 95 comunicazioni a livello internazionale.<\/p>